文献速递骨软组织肉瘤与黑色素瘤

基于组织学与基因组异常的不典型Spitz样肿瘤诊断与预后分类:一项长期随访的前瞻性队列研究

Diagnostic and prognostic classification of atypical spitzoid tumours based on histology and genomic aberrations: A prospective cohort study with long-term follow-up.
PubMed 文献 · Eur J Cancer · 2022-01-31

该前瞻性队列研究对76例组织学意义不明确的不典型Spitz样肿瘤(AST)行阵列比较基因组杂交(aCGH),并由皮肤病理专家组在aCGH前后进行组织学评估,分类为良性、不确定或恶性。结果显示aCGH使47%病例的诊断发生改变,最终分类为良性61%、不确定18%、恶性21%;所有AST预后均良好,长期随访中无远处转移或死亡,染色体异常与预后无相关性。

要点

  • 76例AST中45例(59%)检出染色体异常,中位年龄16岁,中位随访90个月。
  • aCGH结果使36/76例(47%)的初始组织学诊断发生改变。
  • 所有诊断组前哨淋巴结活检阳性率相似(6+/29,P=0.83),且与不良结局无关。

核心结论

  • 所有AST预后均良好,即使形态学令人担忧或存在染色体异常;76例长期随访中无远处转移或死亡,无法评估染色体异常与预后的相关性。
  • 作者认为,在更大队列中,复杂染色体异常的病例可能出现转移,这些患者应接受临床随访。

研究设计与样本

  • 前瞻性队列研究,纳入76例组织学意义不明确的不典型Spitz样肿瘤(AST)患者。
  • 采用阵列比较基因组杂交(aCGH)分析染色体异常,并由皮肤病理专家组在aCGH前后进行组织学评估,分类为良性、不确定或恶性。

主要发现

  • 76例AST中45例(59%)检出染色体异常;中位年龄16岁(范围0-74),中位随访90个月(范围13-153)。
  • aCGH结果使36/76例(47%)的初始组织学诊断发生改变;最终诊断分类为良性61%、不确定18%、恶性21%。
  • 前哨淋巴结活检阳性(6+/29)在各诊断组发生率相似(P=0.83),且与不良结局无关。
  • 2例患者出现局部复发,但无患者发生前哨淋巴结以外的转移。

局限性

  • 76例长期随访中无远处转移或死亡,无法评估染色体异常与预后的相关性。
  • 作者认为在更大队列中,复杂染色体异常的病例可能出现转移,这些患者应接受临床随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Histological classification of atypical spitzoid tumours (ASTs) is unreliable, and categorisation of these lesions into benign and malignant is poorly reproducible. Here, we classified ASTs based on histology and chromosomal aberrations and explored the prognostic significance of genomic aberrations in a prospective cohort with a long-term follow-up. PATIENTS AND METHODS: Histologically equivocal ASTs from 76 patients were analysed by array comparative genomic hybridisation (aCGH). Tumours were histologically assessed by a panel of dermatopathologist before and after aCGH and classified as benign, ambiguous or malignant. Chromosomal aberrations were correlated with an outcome. RESULTS: Chromosomal aberrations were detected in 45 (59%) of 76 ASTs (median age: 16 years, range: 0-74; median follow-up: 90 months, range: 13-153). The initial histological diagnosis was changed upon presentation of aCGH results in 36 of 76 cases (47%). The final diagnostic interpretation classified 61% of the lesions as benign, 18% as ambiguous and 21% as malignant. Positive sentinel lymph node biopsies (6+/29) occurred at similar rates in all diagnostic groups (P = 0.83) and were not associated with an unfavourable outcome. Two patients had local recurrences, but none of the patients developed metastasis beyond the sentinel lymph node. CONCLUSIONS: All ASTs had an excellent prognosis, even in cases with worrisome morphology and chromosomal aberrations. With no distant metastasis or death in long-term follow-up of 76 patients, no correlation between chromosomal aberrations and prognosis was possible. However, it seems likely that in larger cohorts, metastases would arise in cases with complex aberrations and these patients should undergo clinical follow-up.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Gassenmaier M, Soltanpour N, Held L, et al. Diagnostic and prognostic classification of atypical spitzoid tumours based on histology and genomic aberrations: A prospective cohort study with long-term follow-up. Eur J Cancer. 2022. PMID: 35104769. doi:10.1016/j.ejca.2021.12.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。